Mark A. Emalfarb is the founder of the company. He has been a member of the company’s board of directors from October 2004 until the present, serving as its Chairman as well as President and Chief Executive Officer of the company from October 2004 until April 2007 and as Chairman and Chief Executive Officer from June 2008 until the present. Mr. Emalfarb has been a member of the board of directors of the company's wholly owned subsidiary, Dyadic International (USA), Inc., a Florida corporation ("Dyadic-Florida") from its inception until the present, served as its President, Chief Executive Officer and Chairman from its inception until April 2007, and as Chairman and Chief Executive Officer since June 2008. Since founding Dyadic-Florida in 1979, Mr. Emalfarb has successfully led and managed the evolution of Dyadic-Florida from its origins as a pioneer and leader in providing ingredients used in stone-washing of blue jeans to the discovery, development, manufacturing and commercialization of specialty enzymes used in various industrial applications and the development of an integrated technology platform based on the company’s patented and proprietary C1 fungus. Mr. Emalfarb is an inventor of over 25 U.S. and foreign biotechnology patents and patent applications resulting from discoveries related to Dyadic-Florida’s patented and proprietary C1 microorganism, and has been the architect behind its formation of several strategic research and development, manufacturing and marketing relationships with U.S. and international partners. Mr. Emalfarb earned his B.A. degree from the University of Iowa.

Robert D. Burke, MD has been on the company’s board of directors since June 2008 and is a board certified neuroradiologist. Dr. Burke is the founder and, since 1991, the President of Midtown Imaging, LLC, one of South Florida’s leading imaging centers with multiple locations throughout Palm Beach County, Florida. From 1994 to 1996, Dr. Burke was the Founder and President of U.S. Diagnostic Inc., a publicly-traded national diagnostic imaging company which under Dr. Burke’s guidance grew from 30 to 300 million dollars in revenue and market capitalization. Dr. Burke serves on the board of directors of Stonegate Bank, a publicly-traded bank servicing Southeast Florida as well as the board of directors of the Palm Beach County Chapter of the Leukemia & Lymphoma Society. Dr. Burke earned his B.A. degree from the University of Louisville and his medical degree from the University of Louisville School of Medicine. Dr. Burke completed his radiology residency at the University of Chicago and a fellowship in neuroradiology at the University of Rochester.

Frank Gerardi, has been on the company’s board of directors since June 2008. From February 2007 to the present, Mr. Gerardi has been a managing partner at QuantWorks, LLC, a registered investment advisor. From June 2003 to December 2006, Mr. Gerardi was the Chief Executive Officer of IGI, Inc. (now known as IGI Laboratories, Inc.), a publicly-traded company that engages in the development, manufacture, filling, and packaging of topical, semi-solid, and liquid products for pharmaceutical, cosmeceutical, and cosmetic companies. Mr. Gerardi has also served as the President of Univest Management, Inc., a management consulting company since 1986. Mr. Gerardi was a member of the New York Stock Exchange from 1969 to 1986.

Seth J. Herbst, MD has been on the Company’s board of directors since June 2008 and is a board certified obstetrician/gynecologist who specializes in minimally invasive gynecologic surgery. Dr. Herbst is the founder and President of the Institute for Women’s Health and Body, a community based OB/GYN practice with multiple locations in Palm Beach County, Florida. He is also the co-founder of Visions Clinical Research which performs extensive medical and surgical clinical trials throughout the United States. Dr. Herbst received his B.A. degree from American University and his medical degree from Universidad del Noreste School of Medicine in Tampico Mexico.

Stephen J. Warner has been on the company’s board of directors since October 2004, and a director of the company's wholly owned subsidiary, Dyadic International (USA), Inc., a Florida corporation, since August 15, 2004. Mr. Warner is a director of Rock Energy Resources, Inc, a publicly-traded oil and gas production company in Houston Texas, UCT Coatings Inc., a private, metal finishing technology company in Stuart, Florida, and AOI Medical, Inc., a medical device company in Orlando, Florida. Mr. Warner has over 30 years of venture capital experience. In 1981, Mr. Warner founded Merrill Lynch Venture Capital Inc., a wholly owned subsidiary of Merrill Lynch & Co. Inc. in New York and served as its President and Chief Executive Officer from 1981 to 1990. Under his leadership, Merrill Lynch Venture Capital managed over $250 million and made over 50 venture capital investments. In 1999, Mr. Warner co-founded, and became Chairman and CEO, of Crossbow Ventures Inc. (“Crossbow”) until 2004. Crossbow is a private equity fund that invests in early and expansion stage technology companies primarily located in Florida and the Southeast, with over 20 venture capital investments in Florida. Mr. Warner earned a B.S. degree from the Massachusetts Institute of Technology and an MBA from the Wharton School of Business, University of Pennsylvania.